Skip to content
Screener

Phibro Animal Health Corporation PAHC Q4 2026 Annual earnings

Reported August 26, 2026 · After market close

Revenue$396.7MBeat by $15.5M
EPS$0.85Beat by $0.14
Revenue estimate$381.2M
EPS estimate$0.71
“Fiscal 2026 was a year of meaningful progress for Phibro. We delivered record net sales of $1.5 billion, increased Adjusted EBITDA by 39% to $255 million, expanded margins, and continued to improve our business. These results reflect the dedication of our employees around the world and the value of our diversified portfolio.”
Dani Bendheim

Next report

Nov 4, 2026 (in 2 months)
Revenue estimate$379.4M
EPS estimate$0.77

Financials

Q4 2026

Income statement

See full
Revenue$396.7M+4.8%
Gross profit$134.4M+22.2%
Operating income$48.2M+42.8%
Net income$21.7M+26.0%
EPS (diluted)$0.53+23.3%

Balance sheet

See full
Cash & equivalents$61.4M-9.7%
Total debt$56.0M-5.3%
Total equity$385.5M+34.9%
Total assets$1.5B+10.3%

Cash flow

See full
Operating cash flow$24.1M+13.3%
CapEx$18.9M+43.6%
Free cash flow$5.2M-35.7%

Valuation & ratios

Valuation

as of 09/17/26
See full
Market cap$1.43B-8.3%
Enterprise value$1.43B-8.2%
P/E14.4×-18.0×
P/S0.9×-0.3×

Profitability

See full
Gross margin33.8%+2.9pp
Operating margin12.8%+4.3pp
Net margin6.6%+2.8pp
FCF margin0.6%-2.6pp

Returns & leverage

See full
Return on equity29.7%+11.9pp
Debt / equity0.1×-0.1×
Current ratio3×+0.2×

Segments

By product

See full
Medicated Feed Additives And Others$207.6M+0.5%
Mineral Nutrition$77.0M+20.0%
Nutritional Specialties$49.9M+5.3%
Vaccines$40.1M+3.8%
Performance Products$22.2M+0.6%

By geography

See full
Latin America And Canada$90.2M+7.3%
EMEA$53.7M-6.7%
Asia Pacific$32.5M-7.2%

By segment

See full
Mineral Nutrition$77.0M+20.0%
Performance Products$22.2M+0.6%

FAQ

When did Phibro Animal Health Corporation report Q4 2026 earnings?
Phibro Animal Health Corporation (PAHC) reported Q4 2026 earnings on August 26, 2026 after market close.
What were Phibro Animal Health Corporation's Q4 2026 revenue and EPS?
Phibro Animal Health Corporation reported revenue of $396.7M and eps of $0.85 for Q4 2026.
Did Phibro Animal Health Corporation beat estimates in Q4 2026?
Revenue beat the consensus estimate of $381.2M by $15.5M. EPS beat the consensus estimate of $0.71 by $0.14.
How did Phibro Animal Health Corporation's Q4 2026 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 4.8% from $378.7M a year earlier and eps grew 49.1% from $0.57.
Where can I find Phibro Animal Health Corporation's Q4 2026 SEC filings?
You can read the 8-K earnings release (0001104659-26-101531) and the 10-K periodic report (0001104659-26-101493) directly on SEC EDGAR. The filing index links above go to sec.gov.